Infliximab and human immunodeficiency virus infection: Viral load reduction and CD4+ T-cell loss related to apoptosis.
Filippi
Jérôme
J
Roger
Pierre-Marie
PM
Schneider
Stéphane M
SM
Durant
Jacques
J
Breittmayer
Jean-Philippe
JP
Benzaken
Sylvia
S
Bernard
Alain
A
Dellamonica
Pierre
P
Hébuterne
Xavier
X
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D017209:Apoptosis / Q000187:drug effects*; D051940:B7-2 Antigen / Q000378:metabolism; D018791:CD4 Lymphocyte Count; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D000069285:Infliximab; D019562:Viral Load
D000911:Antibodies, Monoclonal; D051940:B7-2 Antigen; D005765:Gastrointestinal Agents; D000069285:Infliximab